AlphaStocks
4.9
Weak

Neogen Corp (NEOG)

As of Sep 20, 2026, Neogen Corp (NEOG) scores 4.9/10 on AlphaStocks' five-model composite, #117 of 168 Health Care stocks. At $13, NEOG trades 27% above its model fair value of $10.

Health Care / Health Care Supplies

S&P SmallCap 600

$13.00

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#117out of 168 in Health Care

Is NEOGEN CORP a Good Investment in 2026?

NEOGEN CORP (NEOG) scores 4.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating NEOGEN CORP as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -37.2% · ROC -143%. NEOGEN CORP currently trades 27% above its estimated fair value of $10. NEOGEN CORP ranks #117 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-46.2Market Cap3B

Estimated Fair Value

$10.2527% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -37.2% · ROC -143%

Frequently Asked Questions

Is NEOGEN CORP (NEOG) a good investment?
As of Sep 20, 2026, Neogen Corp (NEOG) scores 4.9/10 on AlphaStocks' five-model composite, #117 of 168 Health Care stocks. At $13, NEOG trades 27% above its model fair value of $10. That score is below average, suggesting caution.
What is NEOGEN CORP's Piotroski F-Score?
NEOGEN CORP's Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is NEOG overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $10, NEOG appears overvalued. The stock currently trades 27% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does NEOG compare to other Health Care stocks?
NEOGEN CORP ranks #117 out of 168 stocks in the Health Care sector, placing it in the top 70% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about NEOG?
AlphaStocks evaluates NEOG using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.9/10.

Similar Stocks

WSTLNTHMMSI

Compare NEOG with

NEOG vs WSTLNTH vs NEOGMMSI vs NEOG

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer